Pfizer slashes 2023 revenue forecast on lower COVID sales; will cut expenses, jobs
A company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna Geron/File Photo Acquire Licensing RightsOct 13 (Reuters) – Pfizer (PFE.N) on Friday slashed its full-year revenue forecast by 13% and said it will cut $3.5 billion worth of jobs and expenses due to lower-than-expected sales of its COVID-19 vaccine